
CAS Number20357-25-9
Synonyms4,5-dimethoxy-2-nitro-benzaldehyde; Benzaldehyde,4,5-dimethoxy-2-nitro; 3,4-Dimethoxy-6-nitrobenzaldehyde; 6-Nitroveratraldehyde; 2-nitro-4,5-dimethoxybenzaldehyde; DMNB; EINECS 243-762-1; MFCD00007134
Molecular FormulaC9H9NO5
Molecular Weight211.17
Purity≥90 (GC)%
Density1.312 g/cm3
Boiling Point390.8ºC at 760 mmHg
Melting Point133.2-134.5 °C
Appearancesolid
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 20357-25-9 |
| Catalog No. | 2A-9038391 |
| Chinese Name | 6-硝基藜芦醛 |
| Synonyms | 4,5-dimethoxy-2-nitro-benzaldehyde; Benzaldehyde,4,5-dimethoxy-2-nitro; 3,4-Dimethoxy-6-nitrobenzaldehyde; 6-Nitroveratraldehyde; 2-nitro-4,5-dimethoxybenzaldehyde; DMNB; EINECS 243-762-1; MFCD00007134 |
| Molecular Formula | C9H9NO5 |
| Molecular Weight | 211.17 |
| Purity | ≥90 (GC) |
| Density | 1.312 g/cm3 |
| Boiling Point | 390.8ºC at 760 mmHg |
| Melting Point | 133.2-134.5 °C |
| Appearance | solid |
| Water Solubility | DMSO: 22 mg/mL |
| Storage Condition | Dispose under dry protective gas, Keep receptacles |
| Application | DMNB (6-nitroveratraldehyde) is a precursor that can be used to synthesize no carriers added with 6-[18F]fluoro-L-dopa (6-FDOPA). 6-[18F]fluoro-L-dopa (6-FDOPA) without added carrier (NCA) is routinel |
| HTC | 2913000090 |
| MDL Number | MFCD00007134 |
| SMILES | [N+](=O)([O-])c1c(cc(c(c1)OC)OC)C=O |
| InChI | 1S/C9H9NO5/c1-14-8-3-6(5-11)7(10(12)13)4-9(8)15-2/h3-5H,1-2H3 |
| InChI Key | YWSPWKXREVSQCA-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352100 |
| Hazard Symbols | transportation |
| MSDS | msds/38391_1_20357_25_9.pdf |
| Bioactivity | DMNB (6-Nitroveratraldehyde), a precursor, can be used for the synthesis no-carrier-added 6-[18F]fluoro-L-DOPA (6-FDOPA). No-Carrier-Added (NCA) 6-[18F]fluoro-L-dopa (6-FDOPA) is being produced routinely for PET investigations of dopaminergic systems[1]. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease References [1]. Zhang Lan, et al. Preparation of 6-[18F]fluoro-L-DOPA and its biodistribution in normal and unilateral PD model rats. Nuclear Science and Techniques, 13(4), 244-250. [2]. Reddy GN, et al. Quality assurance and quality control methods for animal and human applications of no-carrier-added 6-[18F]fluorodopa for PET investigations of dopaminergic systems. Appl Radiat Isot. 1993;44(7):993-998. Chemical & Physical Properties Density 1.312 g/cm3 Boiling Point 390.8ºC at 760 mmHg Melting Point 133.2-134.5 °C Molecular Formula C9H9NO5 Molecular Weight 211.17100 Flash Point 194.3ºC Exact Mass 211.04800 PSA 81.35000 LogP 1.94770 Vapour Pressure 2.59E-06mmHg at 25°C Index of Refraction 1.571 InChIKey YWSPWKXREVSQCA-UHFFFAOYSA-N SMILES COc1cc(C=O)c([N+](=O)[O-])cc1OC Storage condition 2-8°C Water Solubility DMSO: 22 mg/mL |
| Use of | DMNB (6-Nitroveratraldehyde), a precursor, can be used for the synthesis no-carrier-added 6-[18F]fluoro-L-DOPA (6-FDOPA). No-Carrier-Added (NCA) 6-[18F]fluoro-L-dopa (6-FDOPA) is being produced routinely for PET investigations of dopaminergic systems[1]. Properties Name 4,5-dimethoxy-2-nitrobenzaldehyde Synonym More Synonyms 6-Nitroveratraldehyde Biological Activity Description DMNB (6-Nitroveratraldehyde), a precursor, can be used for the synthesis no-carrier-added 6-[18F]fluoro-L-DOPA (6-FDOPA). No-Carrier-Added (NCA) 6-[18F]fluoro-L-dopa (6-FDOPA) is being produced routinely for PET investigations of dopaminergic systems[1]. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease References [1]. Zhang Lan, et al. Preparation of 6-[18F]fluoro-L-DOPA and its biodistribution in normal and unilateral PD model rats. Nuclear Science and Techniques, 13(4), 244-250. [2]. Reddy GN, et al. Quality assurance and quality control methods for animal and human applications of no-carrier-added 6-[18F]fluorodopa for PET investigations of dopaminergic systems. Appl Radiat Isot. 1993;44(7):993-998. Chemical & Physical Properties Molecular Formula C9H9NO5 Exact Mass 211.04800 PSA 81.35000 LogP 1.94770 Index of Refraction 1.571 InChIKey YWSPWKXREVSQCA-UHFFFAOYSA-N |
| Tax Rebate | 9.0% |
| Supervision | None MFN tariff: 5.5% Ordinary tariff: 30.0% |
| Transport Info | Product name: Purity: 85.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: No dangerous goods IMDG Code: No dangerous goods International Air Transport Dangerous Regulations: No dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special precautions for users No data available |
| Related Products in Functional Building Blocks | ||
|---|---|---|
| 1,4-Cyclohexanedimethanol bis(3,4-epoxycyclohexanecarboxylate) | 20249-12-1 | 2A-9038345 |
| 2-[3-(Trifluoromethyl)phenoxy]ethanethioamide | 20293-32-7 | 2A-9038362 |
| 2-Bromo-6-nitrobenzaldehyde | 20357-21-5 | 2A-9038388 |
| 4-Methyl-2-nitrobenzaldehyde | 20357-22-6 | 2A-9038389 |
| 5-Methoxy-2-nitrobenzaldehyde | 20357-24-8 | 2A-9038390 |
| Ethyl 2-formyl-1-cyclopropanecarboxylate | 20417-61-2 | 2A-9038405 |
| D-Glucurono-6,3-lactone acetonide | 20513-98-8 | 2A-9038433 |
| Ethyl 2-methylcyclopropane-1-carboxylate | 20913-25-1 | 2A-9038572 |
| Glyoxal bis(N-methyl-N-phenylhydrazone) | 20915-45-1 | 2A-9038573 |
| 2-Ethoxybenzhydrazide | 21018-13-3 | 2A-9038592 |
| Browse all Functional Building Blocks products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA